ADIL
Adial Pharmaceuticals Inc
NASDAQ: ADIL · HEALTHCARE · BIOTECHNOLOGY
$1.55
-0.64% today
Updated 2026-04-29
Market cap
$2.21M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-11.93
Dividend yield
—
52W range
$2 – $30
Volume
0.1M
Adial Pharmaceuticals Inc (ADIL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-170.70%
ROA
-83.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $0.00 | $-817993.00 | — | — | — |
| 2016 | $0.00 | $-420200.00 | — | — | — |
| 2017 | $0.00 | $-1.14M | — | — | — |
| 2018 | $0.00 | $-11.63M | — | — | — |
| 2019 | $0.00 | $-8.59M | — | — | — |
| 2020 | $0.00 | $-10.86M | — | — | — |
| 2021 | $0.00 | $-19.42M | — | — | — |
| 2022 | $0.00 | $-12.73M | — | — | — |
| 2023 | $0.00 | $-7.00M | — | — | — |
| 2024 | $0.00 | $-13.20M | — | — | — |
| 2025 | $0.00 | $-7.98M | — | — | — |